EAM Global Investors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$2.52M Sell
2022
Q3
$4.35M Buy
2022
Q2
Sell
2022
Q1
$2.15M Hold
2021
Q4
$2.26M Buy